5-MeO-PiPT

5-MeO-PiPT
臨床資料
其他名稱	5-Methoxy-N-propyl-N-isopropyltryptamine
藥物類別	Non-selective serotonin receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen
識別資訊
	IUPAC命名法 N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-(propan-2-yl)propan-1-amine; ;
CAS號	2945111-53-3
PubChem CID	166468735;
化學資訊
化學式	C17H26N2O
摩爾質量	274.41 g·mol−1
3D模型（JSmol）	交互式圖像;
	SMILES CC(C)N(CCC)CCc1c[NH]c2ccc(cc21)OC;
	InChI InChI=1S/C17H26N2O/c1-5-9-19(13(2)3)10-8-14-12-18-17-7-6-15(20-4)11-16(14)17/h6-7,11-13,18H,5,8-10H2,1-4H3; Key:KLRSMSBDLVDLKK-UHFFFAOYSA-N;

5-MeO-PiPT，化學名5-甲氧基-N-丙基-N-異丙基色胺，是一種有機化合物，化學式為C
17H
26N
2O，它據稱具有致幻作用。^[1]它是一種策劃藥，最初於2021年在加拿大卑詩省被發現。^[2]

參考文獻

^ Warren AL, Lankri D, Cunningham MJ, Serrano IC, Parise LF, Kruegel AC, Duggan P, Zilberg G, Capper MJ, Havel V, Russo SJ, Sames D, Wacker D (June 2024). "Structural pharmacology and therapeutic potential of 5-methoxytryptamines". Nature. 630 (8015): 237–246. Bibcode:2024Natur.630..237W. doi:10.1038/s41586-024-07403-2. PMC 11152992. PMID 38720072.
^ Knill A, Tobias S, Matthews J, Ti L. A Report on British Columbia's Unregulated Drug Supply. Drug checking trends across British Columbia, January to December 2021. (PDF). British Columbia Centre on Substance Use (報告). June 2022.